Putting Patients First in COVID-19 Research
Friday, 9 April 2021
IMPROVING THE EXPERIENCE AND HEALTH OUTCOMES FOR STUDY PARTICIPANTS
DESCRIPTION:
PPD has been at the forefront of COVID-19 research and innovative approaches to clinical trial management. The ongoing pandemic brought on unique challenges, not only for clinical trials, but for study participants’ ability to engage throughout a clinical trial. Niklas Morton, PPD’s senior vice president of PPD® Digital, presented at Reuters Pharma Clinical 2021 on how PPD is focusing on the patient to ensure the best experience and outcomes throughout a clinical trial.
IMPROVING THE EXPERIENCE AND HEALTH OUTCOMES FOR STUDY PARTICIPANTS
DESCRIPTION:
PPD has been at the forefront of COVID-19 research and innovative approaches to clinical trial management. The ongoing pandemic brought on unique challenges, not only for clinical trials, but for study participants’ ability to engage throughout a clinical trial. Niklas Morton, PPD’s senior vice president of PPD® Digital, presented at Reuters Pharma Clinical 2021 on how PPD is focusing on the patient to ensure the best experience and outcomes throughout a clinical trial.
SPEAKERS:
Senior Vice President, PPD® Digital
Niklas Morton serves as senior vice president of PPD® Digital. In this role, he oversees the operations and delivery of digitally enabled and decentralized/virtual studies, along with PPD’s robotic automation capabilities.